145 related articles for article (PubMed ID: 35975851)
1. Identification of Potential Drug Therapy for Dermatofibrosarcoma Protuberans with Bioinformatics and Deep Learning Technology.
Liu M; Yang F; Xu Y
Curr Comput Aided Drug Des; 2022; 18(5):393-405. PubMed ID: 35975851
[TBL] [Abstract][Full Text] [Related]
2. Gene Identification and Potential Drug Therapy for Drug-Resistant Melanoma with Bioinformatics and Deep Learning Technology.
Liu M; Xu Y
Dis Markers; 2022; 2022():2461055. PubMed ID: 35915735
[TBL] [Abstract][Full Text] [Related]
3. Identification of drug compounds for keloids and hypertrophic scars: drug discovery based on text mining and DeepPurpose.
Pan Y; Chen Z; Qi F; Liu J
Ann Transl Med; 2021 Feb; 9(4):347. PubMed ID: 33708974
[TBL] [Abstract][Full Text] [Related]
4. Identification of Drug Compounds for Capsular Contracture Based on Text Mining and Deep Learning.
Lu Y; Chen Z; Pan Y; Qi F
Plast Reconstr Surg; 2023 Nov; 152(5):779e-790e. PubMed ID: 36862957
[TBL] [Abstract][Full Text] [Related]
5. Identification of Key Genes and Pathways in Persistent Hyperplastic Primary Vitreous of the Eye Using Bioinformatic Analysis.
Thomas DM; Kannabiran C; Balasubramanian D
Front Med (Lausanne); 2021; 8():690594. PubMed ID: 34485332
[No Abstract] [Full Text] [Related]
6. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
7. Identification of key genes and pathways in scleral extracellular matrix remodeling in glaucoma: Potential therapeutic agents discovered using bioinformatics analysis.
Hu D; Jiang J; Lin Z; Zhang C; Moonasar N; Qian S
Int J Med Sci; 2021; 18(7):1554-1565. PubMed ID: 33746571
[No Abstract] [Full Text] [Related]
8. Identification of core genes and pathways between geriatric multimorbidity and renal insufficiency: potential therapeutic agents discovered using bioinformatics analysis.
Zhang L; Cai J; Xiao J; Ye Z
BMC Med Genomics; 2022 Oct; 15(1):212. PubMed ID: 36209090
[TBL] [Abstract][Full Text] [Related]
9. Identification of Key Genes and Molecular Pathways in Keratoconus: Integrating Text Mining and Bioinformatics Analysis.
Hu D; Lin Z; Jiang J; Li P; Zhang Z; Yang C
Biomed Res Int; 2022; 2022():4740141. PubMed ID: 36051483
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially expressed genes and signaling pathways using bioinformatics in interstitial lung disease due to tyrosine kinase inhibitors targeting the epidermal growth factor receptor.
Lu Y; Li A; Lai X; Jiang J; Zhang L; Zhong Z; Zhao W; Tang P; Zhao H; Ren X
Invest New Drugs; 2019 Apr; 37(2):384-400. PubMed ID: 30203136
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes and pathways in pelvic organ prolapse based on gene expression profiling by bioinformatics analysis.
Zhou Q; Hong L; Wang J
Arch Gynecol Obstet; 2018 May; 297(5):1323-1332. PubMed ID: 29546564
[TBL] [Abstract][Full Text] [Related]
14. Identification of Essential Genes and Drug Discovery in Bladder Cancer and Inflammatory Bowel Disease
Zheng Q; Guo L; Yang R; Chen Z; Liu X
Curr Comput Aided Drug Des; 2024; 20(4):359-366. PubMed ID: 37005401
[TBL] [Abstract][Full Text] [Related]
15. A comparison expression analysis of CXCR4, CXCL9 and Caspase-9 in dermal vascular endothelial cells between keloids and normal skin on chemotaxis and apoptosis.
Dong X; Zhang M; Chen Y; Li C; Wang Y; Jin X
J Plast Surg Hand Surg; 2022 Apr; 56(2):93-102. PubMed ID: 34110956
[TBL] [Abstract][Full Text] [Related]
16. A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans.
Delyon J; Porcher R; Battistella M; Meyer N; Adamski H; Bertucci F; Guillot B; Jouary T; Leccia MT; Dalac S; Mortier L; Ghrieb Z; Da Meda L; Vicaut E; Pedeutour F; Mourah S; Lebbe C
J Invest Dermatol; 2021 Apr; 141(4):761-769.e2. PubMed ID: 32956651
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
McArthur GA; Demetri GD; van Oosterom A; Heinrich MC; Debiec-Rychter M; Corless CL; Nikolova Z; Dimitrijevic S; Fletcher JA
J Clin Oncol; 2005 Feb; 23(4):866-73. PubMed ID: 15681532
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
20. Targeted therapy for dermatofibrosarcoma protuberans.
Abrams TA; Schuetze SM
Curr Oncol Rep; 2006 Jul; 8(4):291-6. PubMed ID: 17254529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
